fda tirzepatide update today ban on compounded tirzepatide: Switch to name brand medications The FDA says it's standing
Description
Surgery is only required in 1020% of cases where there is gangrene, perforation, or severe complications
Alternatives to liraglutide and semaglutide for weight loss As interest in GLP-1 medications for weight loss grows, so do the available options
The Alliance for Pharmacy Compounding, the trade group for pharmacy compounders, says that an end to the name brand shortages would mean changes for compounding pharmacists
Yet with over 40% of American adults living with obesity, meeting demand has been a challenge
